CIRCULAR RNA AND USE THEREOF

The present invention relates to a circular RNA and a use thereof, and more specifically to a circular RNA which is more stable in vivo than a linear RNA. The circular RNA, according to the present invention, has been confirmed through experiments to have higher stability than a linear RNA, even whe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: CHO, Hyun Jun, CHO, Young Ran, HEO, Hun, CHEONG, Mi Sun, CHO, Byung Mun, PARK, Young Keun, KIM, Shin Young, SONG, Min Ah, KAR, Muthumani, KIM, Bo Young, LEE, Ji Won, JUNG, Ji Yun
Format: Patent
Sprache:eng ; fre ; kor
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention relates to a circular RNA and a use thereof, and more specifically to a circular RNA which is more stable in vivo than a linear RNA. The circular RNA, according to the present invention, has been confirmed through experiments to have higher stability than a linear RNA, even when treated with RNase, and to have higher stability than a linear RNA, even when stored for a long time. This means that the circular RNA of the present invention has high in vitro or in vivo stability and thus enables the in vitro or in vivo expression of a target protein to be sustained for a long time. Thus, the circular RNA of the present invention may be used in various ways as a platform for the prevention or treatment of a target disease, or as a vaccine platform for the prevention of infection of a target disease. La présente invention concerne un ARN circulaire et son utilisation, et plus particulièrement un ARN circulaire plus stable in vivo qu'un ARN linéaire. Des expériences ont confirmé que l'ARN circulaire, selon la présente invention, possède une plus grande stabilité qu'un ARN linéaire, même lorsqu'il est traité à la RNase, et qu'il possède une plus grande stabilité qu'un ARN linéaire, même lorsqu'il est stocké pendant une longue période. Ceci signifie que l'ARN circulaire de la présente invention présente une stabilité in vitro ou in vivo élevée et permet ainsi de maintenir l'expression in vitro ou in vivo d'une protéine cible pendant une longue durée. Ainsi, l'ARN circulaire de la présente invention peut être utilisé de diverses manières en tant que plate-forme pour la prévention ou le traitement d'une maladie cible, ou en tant que plate-forme vaccinale pour la prévention d'une infection d'une maladie cible. 본 발명은 원형 RNA 및 이의 이용에 관한 것으로, 보다 상세하게는 생체 내에서 선형 RNA보다 안정한 원형 RNA에 관한 것이다. 본 발명에 따른 원형 RNA는 RNase를 처리하였음에도 선형 RNA보다 안정성이 높고, 오랜시간 보관하여도 선형 RNA보다 안정성이 높은 것을 실험적으로 확인하였다. 이는 본 발명의 원형 RNA가 시험관 내 또는 생체 내에서 안정성이 높은바, 시험관 내 또는 생체 내에서 목적 단백질의 발현을 오랫동안 유지할 수 있음을 의미한다. 따라서 본 발명의 원형 RNA는 목적 질환의 예방 또는 치료를 위한 플랫폼; 또는 목적 질환의 감염 예방을 위한 백신 플랫폼;으로 다양하게 활용될 수 있다.